Myostatin modulates adipogenesis to generate adipocytes with favorable metabolic effects

被引:172
作者
Feldman, Brian J.
Streeper, Ryan S.
Farese, Robert V., Jr.
Yamamoto, Keith R. [1 ]
机构
[1] Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA
[5] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94143 USA
关键词
diabetes; obesity;
D O I
10.1073/pnas.0607501103
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
A pluripotent cell line, C3H10T1/2, is induced to undergo adipogenesis by a mixture of factors that includes a glucocorticoid such as dexamethasone. We found that expression of myostatin (MSTN), a TGF-beta family member extensively studied in muscle, was induced by dexamethasone under those differentiation conditions. Moreover, MSTN could substitute for dexamethasone in the adipogenesis mixture. However, the adipocytes induced by MSTN in both cell culture and transgenic mice were small and expressed markers characteristic of immature adipocytes. These adipocytes exhibited cell-autonomous increases in insulin sensitivity and glucose oxidation. In mice, these effects produced elevated systemic insulin sensitivity and resistance to diet-induced obesity. Modulation of the final stages of adipogenesis may provide a novel approach to understanding and treating metabolic disease.
引用
收藏
页码:15675 / 15680
页数:6
相关论文
共 22 条
[1]  
Am Diabetes Assoc, 2006, DIABETES CARE, V29, pS4
[2]   Myostatin inhibits myogenesis and promotes adipogenesis in C3H 10T(1/2) mesenchymal multipotent cells [J].
Artaza, JN ;
Bhasin, S ;
Magee, TR ;
Reisz-Porszasz, S ;
Shen, RQ ;
Groome, NP ;
Fareez, MM ;
Gonzalez-Cadavid, NF .
ENDOCRINOLOGY, 2005, 146 (08) :3547-3557
[3]   Regulation of osteoblastogenesis and bone mass by Wnt10b [J].
Bennett, CN ;
Longo, KA ;
Wright, WS ;
Suva, LJ ;
Lane, TF ;
Hankenson, KD ;
MacDougald, OA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (09) :3324-3329
[4]  
HIRAI S, 2006, IN PRESS DOMEST ANIM
[5]   Adipose tissue as an endocrine organ [J].
Kershaw, EE ;
Flier, JS .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06) :2548-2556
[6]   Inhibition of preadipocyte differentiation by myostatin treatment in 3T3-L1 cultures [J].
Kim, HS ;
Liang, L ;
Dean, RG ;
Hausman, DB ;
Hartzell, DL ;
Baile, CA .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 281 (04) :902-906
[7]   Need for GLUT4 activation to reach maximum effect of insulin-mediated glucose uptake in brown adipocytes isolated from GLUT4myc-expressing mice [J].
Konrad, D ;
Bilan, PJ ;
Nawaz, Z ;
Sweeney, G ;
Niu, WY ;
Liu, Z ;
Antonescu, CN ;
Rudich, A ;
Klip, A .
DIABETES, 2002, 51 (09) :2719-2726
[8]   Myostatin knockout in mice increases myogenesis and decreases adipogenesis [J].
Lin, J ;
Arnold, HB ;
Della-Fera, MA ;
Azain, MJ ;
Hartzell, DL ;
Baile, CA .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 291 (03) :701-706
[9]   Characterization of 5′-regulatory region of human myostatin gene:: regulation by dexamethasone in vitro [J].
Ma, K ;
Mallidis, C ;
Artaza, J ;
Taylor, W ;
Gonzalez-Cadavid, N ;
Bhasin, S .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2001, 281 (06) :E1128-E1136
[10]   Adipogenesis: forces that tip the scales [J].
MacDougald, OA ;
Mandrup, S .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2002, 13 (01) :5-11